Placebo response is one of the most significant barriers to detecting treatment effects in pediatric (and adult) clinical trials focusing on affective and anxiety disorders. We sought to identify neurofunctional predictors of placebo response in adolescents with generalized anxiety disorder (GAD) by examining dynamic and static functional brain connectivity.
Methods:
Before randomization to blinded placebo, adolescents, aged 12–17 years, with GAD (N = 25) underwent resting state functional magnetic resonance imaging. Whole brain voxelwise correlation analyses were used to determine the relationship between change in anxiety symptoms from baseline to week 8 and seed-based dynamic and static functional connectivity maps of regions in the salience and ventral attention networks (amygdala, dorsal anterior cingulate cortex [dACC], and ventrolateral prefrontal cortex [VLPFC]).
Results:
Greater dynamic functional connectivity variability in amygdala, dACC, VLPFC, and regions within salience, default mode, and frontoparietal networks was associated with greater placebo response. Lower static functional connectivity between amygdala and dorsolateral prefrontal cortex, amygdala and medial prefrontal cortex, dACC and posterior cingulate cortex and greater static functional connectivity between VLPFC and inferior parietal lobule were associated with greater placebo response.
Conclusion:
Placebo response is associated with a distinct dynamic and static connectivity fingerprint characterized by “variable” dynamic but “weak” static connectivity in the salience, default mode, frontoparietal, and ventral attention networks. These data provide granular evidence of how circuit-based biotypes mechanistically relate to placebo response. Finding biosignatures that predict placebo response is critically important in clinical psychopharmacology and to improve our ability to detect medication-placebo differences in clinical trials.
Get full access to this article
View all access options for this article.
References
1.
AllenEA, DamarajuE, PlisSM, ErhardtEB, EicheleT, CalhounVD: Tracking whole-brain connectivity dynamics in the resting state. Cereb Cortex, 24:663–676, 2014.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of MentalDisorders, 4th ed., TextRevision. Washington, DC: American Psychiatric Association; 2000.
3.
Andrews-HannaJR, SmallwoodJ, SprengRN: The default network and self-generated thought: Component processes, dynamic control, and clinical relevance. Ann N Y Acad Sci, 1316:29–52, 2014.
BackesH, DietscheB, NagelsA, StratmannM, KonradC, KircherT, KrugA: Increased neural activity during overt and continuous semantic verbal fluency in major depression: Mainly a failure to deactivate. Eur Arch Psychiatry Clin Neurosci, 264:631–645, 2014.
6.
BastenU, StelzelC, FiebachCJ: Trait anxiety modulates the neural efficiency of inhibitory control. J Cogn Neurosci, 23:3132–3145, 2011.
7.
BeesdoK, LauJYF, GuyerAE, McClure-ToneEB, MonkCS, NelsonEE, FrommSJ, GoldwinMA, WittchenHU, LeibenluftE, ErnsM, PineDS: Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry, 66:275–285, 2009.
8.
BenedettiF, MaybergHS, WagerTD, StohlerCS, ZubietaJK: Neurobiological mechanisms of the placebo effect. J Neurosci, 25:10390–10402, 2005.
9.
BlackfordJU, PineDS: Neural substrates of childhood anxiety disorders: A review of neuroimaging findings. J Child Adolesc Psychiatr Clin N Am, 21:501–525, 2012.
10.
BridgeJA, BirmaherB, IyengarS, BarbeRP, BrentDA: Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry, 166:42–49, 2009.
11.
BrittonJC, GrillonC, LissekS, NorcrossMA, SzuhanyKL, ChenG, ErnstM, NelsonEE, LeibenluftE, ShechnerT, PineDS: Response to learned threat: An fMRI study in adolescent and adult anxiety. Am J Psychiatry, 170:1195–1204, 2013.
12.
BrownV, PecinaM: Neuroimaging studies of antidepressant placebo effects: Challenges and opportunities. Front Psychiatry, 10:669, 2019.
13.
CaporinoNE, BrodmanDM, KendallPC, AlbanoAM, SherrillJ, PiacentiniJ, SakolskyD, BirmaherB, ComptonSN, GinsburgG, RynnM, McCrackenJ, GoschE, KeetonC, MarchJ, WalkupJT: Defining treatment response and remission in child anxiety: Signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry, 52:57–67, 2013.
14.
ClaussJA, BenningfieldMM, RaoU, BlackfordJU: Altered prefrontal cortex function marks heightened anxiety risk in children. J Am Acad Child Adolesc Psychiatry, 55:809–816, 2016.
15.
CohenD, ConsoliA, BodeauN, Purper-OuakilD, DeniauE, GuileJM, DonnellyC: Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders. J Child Adolesc Psychopharmacol, 20:39–47, 2010.
16.
DobsonET, StrawnJR: Placebo response in pediatric anxiety disorders: Implications for clinical trial design and interpretation. J Child Adolesc Psychopharmacol, 26:686–693, 2016.
17.
EmslieGJ, PrakashA, ZhangQ, PangalloBA, BangsME, MarchJS: A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol, 24:170–179, 2014.
18.
EtkinA, PraterKE, SchatzbergAF, MenonV, GreiciusMD: Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry, 66:1361–1372, 2009.
19.
FanLZ, LiH, ZhuoJJ, ZhangY, WangJJ, ChenLF, YangZY, ChuCY, XieSM, LairdAR, FoxPT, EickhoffSB, YuCS, JiangTZ: The human brainnetome atlas: A new brain atlas based on connectional architecture. Cereb Cortex, 26:3508–3526, 2016.
20.
Fonseca PachiCG, TorralboL, YamamotoJF: Alzheimer's Disease and the Volume of Hippocampal Subfields: Cluster Analysis Using Neuroimaging Data. Cham, Switzerland: Springer International Publishing, 2019, pp. 296–306.
FuXX, Taber-ThomasBC, Perez-EdgarK: Frontolimbic functioning during threat-related attention: Relations to early behavioral inhibition and anxiety in children. Biol Psychol, 122:98–109, 2017.
GrabbMC, CrossAJ, PotterWZ, McCrackenJT: Derisking psychiatric drug development: The NIMH's fast fail program, a novel precompetitive model. J Clin Psychopharmacol, 36:419–421, 2016.
25.
GuyW: The clinical global impression scale. In: ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: U.S. Department of Health, Education & Welfare, 1976.
26.
GuyerAE, MastenCL, PineDS: Pediatric anxiety disorders: A clinical guide. In: Pediatric Anxiety Disorders: A Clinical Guide. Edited by VasaRA, Roy AK. New York: Springer Science + Business Media, 2013, pp. 23–46.
27.
HardeeJE, BensonBE, Bar-HaimY, MoggK, BradleyBP, ChenG, BrittonJC, ErnstM, FoxNA, PineDS, Perez-EdgarK: Patterns of neural connectivity during an attention bias task moderate associations between early childhood temperament and internalizing symptoms in young adulthood. Biol Psychiatry, 74:273–279, 2013.
KrystalAD, PizzagalliDA, MathewSJ, SanacoraG, KeefeR, SongA, CalabreseJ, GoddardA, GoodmanW, LisanbySH, SmoskiM, WeinerR, IosifescuD, NurnbergerJ, SzaboS, MurroughJ, ShekharA, PotterW: The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nat Rev Drug Discov, 18:82–84, 2019.
33.
KucyiA, HoveMJ, EstermanM, HutchisonRM, ValeraEM: Dynamic brain network correlates of spontaneous fluctuations in attention. Cereb Cortex, 27:1831–1840, 2017.
34.
KujawaA, SwainJE, HannaGL, KoschmannE, SimpsonD, ConnollyS, FitzgeraldKD, MonkCS, PhanKL: Prefrontal reactivity to social signals of threat as a predictor of treatment response in anxious youth. Neuropsychopharmacology, 41:1983–1990, 2016.
35.
LiJ, BiswalBB, WangP, DuanX, CuiQ, ChenH, LiaoW: Exploring the functional connectome in white matter. Hum Brain Mapp, 40:4331–4344, 2019a.
36.
LiJ, DuanXJ, CuiQ, ChenHF, LiaoW: More than just statics: Temporal dynamics of intrinsic brain activity predicts the suicidal ideation in depressed patients. Psychol Med, 49:852–860, 2019b.
37.
LiWQ, MaiXQ, LiuC: The default mode network and social understanding of others: What do brain connectivity studies tell us. Front Hum Neurosci, 8:74, 2014.
38.
LiaoW, LiJ, DuanXJ, CuiQ, ChenH, ChenHF: Static and dynamic connectomics differentiate between depressed patients with and without suicidal ideation. Hum Brain Mapp, 39:4105–4118, 2018.
39.
LiaoW, WuGR, XuQ, JiGJ, ZhangZ, ZangYF, LuG: DynamicBC: A MATLAB toolbox for dynamic brain connectome analysis. Brain Connect, 4:780–790, 2014.
40.
MaybergHS, SilvaJA, BrannanSK, TekellJL, MahurinRK, McGinnisS, JerabekPA: The functional neuroanatomy of the placebo effect. Am J Psychiatry, 159:728–737, 2002.
41.
MonkCS, NelsonEE, McClureEB, MoggK, BradleyBP, LeibenluftE, BlairRJR, ChenG, CharneyDS, ErnstM, PineDS: Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry, 163:1091–1097, 2006.
42.
MonkCS, TelzerEH, MoggK, BradleyBP, MaiXQ, LouroHMC, ChenG, McClure-ToneEB, ErnstM, PineDS: Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry, 65:568–576, 2008.
43.
MuellerSC, AouidadA, GorodetskyE, GoldmanD, PineDS, ErnstM: Gray matter volume in adolescent anxiety: an impact of the brain-derived neurotrophic factor Val(66)Met polymorphism?. J Am Acad Child Adolesc Psychiatry, 52:184–195, 2013.
44.
PecinaM, BohnertASB, SikoraM, AveryET, LangeneckerSA, MickeyBJ, ZubietaJK: Association between placebo-activated neural systems and antidepressant responses neurochemistry of placebo effects in major depression. JAMA Psychiatry, 72:1087–1094, 2015.
45.
PowersMB, WhitleyD, TelchMJ, SmitsJAJ, BystritskyA: The effect of attributional processes concerning medication taking on return of fear. J Consult Clin Psychol, 76:478–490, 2008.
46.
PretiMG, Van de VilleD: Dynamics of functional connectivity at high spatial resolution reveal long-range interactions and fine-scale organization. Sci Rep, 7:12773, 2017.
47.
QiuC, LiaoW, DingJ, FengY, ZhuC, NieX, ZhangW, ChenH, GongQ: Regional homogeneity changes in social anxiety disorder: A resting-state fMRI study. Psychiatry Res, 194:47–53, 2011.
48.
RiddleMA, GinsburgGS, WalkupJT, LabelarteMJ, PineDS, DaviesM, GreenhillL, SweeneyM, KleinR, AbikoffH, HackS, KleeB, BergmanL, MarchJ, ComptonS, RobinsonJ, O'HaraT, BakerS, RitzL, RoperM, AnxietyPP: The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. J Am Acad Child Adolesc Psychiatry, 41:1061–1069, 2002.
49.
RogersCE, SylvesterCM, MintzC, KenleyJK, ShimonyJS, BarchDM, SmyserCD: Neonatal amygdala functional connectivity at rest in healthy and preterm infants and early internalizing symptoms. J Am Acad Child Adolesc Psychiatry, 56:157–166, 2017.
50.
RoyAK, FudgeJL, KellyC, PerryJSA, DanieleT, CarlisiC, BensonB, CastellanosFX, MilhamMP, PineDS, ErnstM: Intrinsic functional connectivity of amygdala-based networks in adolescent generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry, 52:290–299, 2013.
51.
RoyallDR, PalmerRF, VidoniED, HoneaRA: The default mode network may be the key substrate of depressive symptom-related cognitive changes. J Alzheimers Dis, 34:547–560, 2013.
52.
ShirerWR, RyaliS, RykhlevskaiaE, MenonV, GreiciusMD: Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex, 22:158–165, 2012.
53.
SilvermanWK, AlbanoAM: Anxiety Disorders Interview Schedule for DSM-IV-Child Version: Clinician Manual. San Antonio, TX: Psychological Corporation, 1996.
StrawnJR, LuL, PerisT, LevineA, JTW: Pediatric anxiety disorders: What have we learnt in the last 10 years?. J Child Psychol Psychiatry [Epub ahead of print]; DOI: 10.1111/jcpp.13262.
StrawnJR, WehryAM, ChuWJ, AdlerCM, EliassenJC, CerulloMA, StrakowskiSM, DelBelloMP: Neuroanatomic abnormalities in adolescents with generalized anxiety disorder: A voxel-based morphometry study. Depress Anxiety, 30:842–848, 2013.
63.
SylvesterCM, CorbettaM, RaichleME, RodebaughTL, SchlaggarBL, ShelineYI, ZorumskiCF, LenzEJ: Functional network dysfunction in anxiety and anxiety disorders. Trends Neurosci, 35:527–535, 2012.
64.
SylvesterCM, SmyserCD, SmyserT, KenleyJ, AckermanJJ, ShimonyJS, PetersenSE, RogersCE: Cortical functional connectivity evident after birth and behavioral inhibition at age 2. Am J Psychiatry, 175:180–187, 2018.
65.
TianX, WeiDT, DuX, WangKC, YangJY, LiuW, MengJ, LiuHJ, LiuGY, QiuJ: Assessment of trait anxiety and prediction of changes in state anxiety using functional brain imaging: A test–retest study. Neuroimage, 133:408–416, 2016.
66.
WalkupJT: Antidepressant efficacy for depression in children and adolescents: Industry- and NIMH-funded studies. Am J Psychiatry, 174:430–437, 2017.
67.
WalkupJT, AlbanoAM, PiacentiniJ, BirmaherB, ComptonSN, SherrillJT, GinsburgGS, RynnMA, McCrackenJ, WaslickB, IyengarS, MarchJS, KendallPC: Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med, 359:2753–2766, 2008.
68.
WangY, BernankeJ, PetersonBS, McGrathP, StewartJ, ChenY, LeeS, WallM, BastidasV, HongS, RutherfordBR, HellersteinDJ, PosnerJ: The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: A treatment mechanism study. Lancet Psychiatry, 6:667–674, 2019.
69.
WeaverKE, ChaovalitwongseWA, NovotnyEJ, PoliakovA, GrabowskiTG, OjemannJG: Local functional connectivity as a pre-surgical tool for seizure focus identification in non-lesion, focal epilepsy. Front Neurol, 4:43, 2013.
70.
WilliamsLM: Precision psychiatry: A neural circuit taxonomy for depression and anxiety. Lancet Psychiatry, 3:472–480, 2016.
71.
YanCG, WangXD, ZuoXN, ZangYF: DPABI: Data processing and analysis for (resting-state) brain imaging. Neuroinformatics, 14:339–351, 2016.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
